# Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients

> **NCT02976246** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 123 (actual)

## Conditions studied

- Vitamin K Supplementation
- Endstage Renal Disease
- Cardiovascular Disease
- Bone Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K2 (MK7)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02976246
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2020-06-26
- **Final completion:** —
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976246, "Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02976246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*